Chun-Hong Yu

620 citations
25 papers · 479 indexed · h-index 10
Topics
Epigenetics and DNA Methylation (5 papers)RNA modifications and cancer (5 papers)Retinopathy of Prematurity Studies (4 papers)
Partner nations
ChinaNew Zealand

In The Last Decade

Chun-Hong Yu

25 papers receiving 471 citations

Peers

Chun-Hong Yu
Comparison fields: 5 of 76
  • Molecular Biology 308
  • Cancer Research 94
  • Plant Science 84
  • Cell Biology 70
  • Pharmacology 34
Replace Mei Yan with:
Mei Yan China
Ziyu Liu China
Grzegorz Terlecki Poland
Dajun Liu China
Géraldine Mitou France
Bin Xue China
Nengwang Yu China
Erik Johansson Sweden
Chun-Hong Yu relative to Mei Yan China Mei Yan's profile →
Citations per field
00.5×10×15×20×24×
Mei Yan · 1×
Citations per year

Countries citing papers authored by Chun-Hong Yu

Since Specialization
Citations

This map shows the geographic impact of Chun-Hong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun-Hong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun-Hong Yu more than expected).

Fields of papers citing papers by Chun-Hong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun-Hong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun-Hong Yu. The network helps show where Chun-Hong Yu may publish in the future.

Co-authorship network of co-authors of Chun-Hong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chun-Hong Yu. A scholar is included among the top collaborators of Chun-Hong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun-Hong Yu. Chun-Hong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 3
3 1
4 7
5 2
6 7
7 3
8 8
9 15
10 4
11 57
12
Correlation of interactions between NOS3 polymorphisms and oxygen therapy with retinopathy of prematurity susceptibility.
9
13 5
14 17
15 19
16 82
17 15
18 19
19 71
20
[Role of exogenous Ca2+ in the somatic embryogenesis of Lycium barbarum L].
2

About Chun-Hong Yu

Chun-Hong Yu is a scholar working on Genetics, Cancer Research and Molecular Biology, having authored 25 papers that have together received 479 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), RNA modifications and cancer (5 papers) and Retinopathy of Prematurity Studies (4 papers). The work is most often cited by research in Cancer Research (94 citations), Molecular Biology (308 citations) and Cell Biology (70 citations). Chun-Hong Yu has collaborated with scholars based in China and New Zealand. Frequent co-authors include Liang‐Hu Qu, Hui Zhou, Li‐Ting Diao, Peng Shao, Zhiwei Dong, Hui Zhou, Xiaoxia Gao, Yujie Chen, Qiao-Juan Huang and Huilin Huang. Their work appears in journals such as Nucleic Acids Research, Biochemical and Biophysical Research Communications and Toxicology and Applied Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026